Monte Rosa Therapeutics, Inc. — 4 Filings
106 4 filings on record
This page lists all 4 filings submitted to the SEC by Monte Rosa Therapeutics, Inc. (GLUE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Monte Rosa Therapeutics, Inc. has filed 106 4 documents with the SEC since 2020. To view all SEC filings by Monte Rosa Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-094296 | Mar 5, 2026 | Mar 4, 2026 |
| 4 | 4 | 0001193125-26-091733 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-085677 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-066955 | Feb 24, 2026 | Feb 23, 2026 |
| 4 | 4 | 0001193125-26-008902 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-002385 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002406 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002401 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002389 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-002390 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-002386 | Jan 5, 2026 | Jan 2, 2026 |
| 4 | 4 | 0000950170-25-086702 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086703 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086704 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086727 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086699 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086700 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-086701 | Jun 16, 2025 | Jun 13, 2025 |
| 4 | 4 | 0000950170-25-081637 | Jun 4, 2025 | Jun 3, 2025 |
| 4 | 4 | 0000950170-25-044633 | Mar 25, 2025 | Mar 24, 2025 |
| 4 | 4 | 0000950170-25-002105 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002099 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002100 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002101 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002102 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-25-002103 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | 4 | 0000950170-24-136056 | Dec 13, 2024 | Dec 11, 2024 |
| 4 | 4 | 0000950170-24-119051 | Oct 30, 2024 | Oct 28, 2024 |
| 4 | 4 | 0000950170-24-109112 | Sep 24, 2024 | Sep 20, 2024 |
| 4 | 4 | 0000950170-24-106387 | Sep 13, 2024 | — |
| 4 | 4 | 0000950170-24-106532 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | 4 | 0000950170-24-082416 | Jul 9, 2024 | Jul 5, 2024 |
| 4 | 4 | 0000950170-24-073265 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-073063 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-073062 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-073073 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-073064 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-073059 | Jun 13, 2024 | Jun 12, 2024 |
| 4 | 4 | 0000950170-24-069310 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069309 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069307 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | 4 | 0000950170-24-069308 | Jun 5, 2024 | Jun 3, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000765 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000767 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000769 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000764 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000766 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-000768 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043408 | Jul 26, 2023 | Jul 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-037376 | Jun 15, 2023 | Jun 14, 2023 |